The c-MYC oncogene is variably expressed across different brain tumors types, e.g., in about 70% of glioma, including low and high grade tumors,55 and is amplified in up to 17% of group 3 medulloblastomas, the most common malignant brain tumor in children.56 Here, MYC is linked to central nervous system cancer.